Steven A. Kates
Direktor/Vorstandsmitglied bei American Chemical Society
Aktive Positionen von Steven A. Kates
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
American Chemical Society
 American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Direktor/Vorstandsmitglied | - | - |
American Peptide Society, Inc.
 American Peptide Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Peptide Society, Inc. operates as scientific and educational organization which provides a forum for advancing and promoting knowledge of the chemistry and biology of peptides. The company was founded in 1990 and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | - | - |
| Association of Biomolecular Research Facilities | Corporate Officer/Principal | - | - |
Karriereverlauf von Steven A. Kates
Ehemalige bekannte Positionen von Steven A. Kates
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| DICERNA PHARMACEUTICALS, INC. | General Counsel | 13.06.2019 | 01.11.2022 |
| ARCH THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2007 | - |
Ausbildung von Steven A. Kates
| Bates College | Undergraduate Degree |
| Brandeis University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 8 |
Operativ
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Consumer Services | 3 |
| Commercial Services | 3 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ARCH THERAPEUTICS, INC. | Distribution Services |
| Private Unternehmen | 4 |
|---|---|
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Commercial Services |
American Peptide Society, Inc.
American Peptide Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Peptide Society, Inc. operates as scientific and educational organization which provides a forum for advancing and promoting knowledge of the chemistry and biology of peptides. The company was founded in 1990 and is headquartered in London, the United Kingdom. | Commercial Services |
| Association of Biomolecular Research Facilities |
- Börse
- Insiders
- Steven A. Kates
- Erfahrung